Skip to main content
Caplight Logo









PhytoNext B.V.

PhytoNext B.V.

Private
WageningenHealthcare & Life Scienceshttps://phytonext.org/

Last Round

Grant

Mar 1, 2016

Company Overview

PhytoNext B.V. operates in Healthcare & Life Sciences and is based in Wageningen. Its latest recorded funding round was a Grant round in March 2016.

PhytoNext B.V. is a Dutch plant extraction technology company that develops and licenses a proprietary low-temperature, low-pressure extraction process for selectively isolating phytochemicals from plant biomass for the food, pharmaceutical, and cosmetics industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Circular Economy

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PhytoNext B.V. Comparables

Compare PhytoNext B.V. with similar companies based on industry and business-model similarity.

PhytoNext B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TOP b.v.
81%
FLAVEX Naturextrakte GmbH
77%
Anklam Extrakt GmbH
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PhytoNext B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

PhytoNext B.V. Investors

Notable investors and investment history

PhytoNext B.V. investors
InvestorRounds
Blue Ocean XLeratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2016

    Received grant funding to support operations.

Book a demo to see all signals

For institutional investors. Book with your work email.

PhytoNext B.V. Filings

Explore SEC and related filing metadata, where available.

PhytoNext B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PhytoNext B.V.'s valuation, stock price, and market status.

Is PhytoNext B.V. a public or private company?

PhytoNext B.V. is a private company.

What is the current stock price of PhytoNext B.V.?

PhytoNext B.V. is a private company, so its shares have no public market price. Caplight tracks PhytoNext B.V.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PhytoNext B.V. worth (valuation)?

Valuation information for PhytoNext B.V. is not publicly available.

Can I buy PhytoNext B.V. stock?

PhytoNext B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PhytoNext B.V.'s last funding round?

PhytoNext B.V.'s most recent funding round was Grant on March 1, 2016.

Who are the main investors in PhytoNext B.V.?

Key investors in PhytoNext B.V. include Blue Ocean XLerator.

Will PhytoNext B.V. IPO soon?

No public IPO plans have been announced for PhytoNext B.V..

How can I track PhytoNext B.V. secondary market activity?

Caplight tracks bids, offers, and trades in PhytoNext B.V.'s shares on secondary markets.

Firmographic Details

HeadquartersWageningen
Year Founded2012
Last FundingMar 1, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?